During
our research, we were able to identify the presence of more than 80 players
that are engaged in offering services across the globe.
Majority of the genotoxicity / mutagenicity testingservice providers
(40%) engaged in this domain were established pre-1991. This is indicative of
the growing interest of stakeholders in this domain. Examples of recently
established companies include (post-2010, in alphabetical order) Admescope
(2011), Anax Laboratories (2012) and Aragen Life Sciences (2021). Additionally,
14% companies have entered this domain between 1991 and 2000, indicating that
the market is driven by efforts of well-established players as well. At present, more than 80 players offer a variety
of assays, such as Ames assay, micronucleus assay, chromosomal aberration test,
genetic mutation assay and comet assay, which can be used to evaluate the genetic toxicityof a substance.
To
request a sample copy / brochure of this report, please visit
https://www.rootsanalysis.com/reports/genotoxicity-testing-services-market/request-sample.html
Further,
it was observed that majority of service providers are based in Asia-Pacific
(49%), followed by players based in North America (30%) and Europe (21%). The current market
landscape is dominated by the presence of mid-sized organization (43%). Notable examples include (in
alphabetical order)Anax Laboratories and CSIR – Indian
Institute of Toxicology.
Further,
genotoxicity / mutagenicity testing serviceproviders, focuses on providing services to a wide
range of industries, primarily includes healthcare industry (96%) followed by
chemical industry (46%). It is worth noting that organizations such as Cadila
Pharmaceuticals and DigilanceBio offer services for all types of industries.
According to our proprietary scoring criteria, in North
America, Crown Biosciences has emerged to be relatively superior, in terms of
company strength. The firm offer service through in vivo type of assay.
Further, Charles River Laboratories emerged as one of the
prominent player offering both in vivo and in vitro assays. The
platform has capability to offer services through different assay(s) / test(s)
including Ames Test,
micronucleus test, chromosomal aberration test, genetic mutation test and comet
assay.
For additional details, please visithttps://www.rootsanalysis.com/reports/genotoxicity-testing-services-market.html
You may also be interested in the
following titles:
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market
research. Having worked with over 750 clients worldwide, including Fortune 500
companies, start-ups, academia, venture capitalists and strategic investors for
more than a decade, we offer a highly analytical / data-driven perspective to a
network of over 450,000 senior industry stakeholders looking for credible
market insights.
Contact:
Ben Johnson
+1 (415) 800
3415
[email protected]
The Wall